Isolation and Stimulation of T Cells with Vitamin D and TGF-β
Corresponding Organization : Guy's Hospital
Other organizations : Royal Brompton & Harefield NHS Foundation Trust, National Health Service, Royal Brompton Hospital, NIHR Leicester Biomedical Research Centre, National Institute for Health Research, University of Leicester, University College London, The Royal Free Hospital
Variable analysis
- 1,25(OH)2D3 (BIOMOL research labs, UK)
- TGF-β1 (R&D Systems, UK)
- TGF-β2 (R&D Systems)
- Anti-TGF-β (R&D Systems)
- Not explicitly mentioned
- Plate-bound anti-CD3 (1 μg/ml; OKT3)
- 50 IU/ml recombinant human IL-2 (Eurocetus, UK)
- RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, and 50 μg/ml gentamicin
- Positive control: Plate-bound anti-CD3 (1 μg/ml; OKT3) plus 50 IU/ml recombinant human IL-2 (Eurocetus, UK)
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!